AMGN
Amgen Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#425 today
$403.04
-1.04% today · -2.79% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- AMGN −1.04% on the last session vs SPY +0.74%: −1.8 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 72 big drops in the past 5 years, AMGN typically gained 0.8% over the next month (median) and was higher 56% of the time; half the outcomes fell between -3.8% and +6.3%. An ordinary month: +0.9%. Among S&P 500 stocks after big drops, that ranks #393 of 500.
- 1 insider or congressional trade in the past 30 days.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 3
In 30 days
estimated date
EPS estimate
$5.78
$5.48 to $6.16 · 27 analysts
Revenue estimate
$10.0B
$9.8B to $10.3B
Track record
8/8 beats
last 8 reports · moved ±4.9% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 AMC | 2Q2026 | $5.62 | $6.29 | +$0.67 (+12.0%) beat | — | +4.6% +4.8 vs SPY | +0.9% | +6.2% |
| Apr 30, 2026 AMC | 1Q2026 | $4.77 | $5.15 | +$0.38 (+8.0%) beat | $8.6B | -4.8% -5.0 vs SPY | -4.0% | -5.0% |
| Feb 3, 2026 AMC | 4Q2025 | $4.73 | $5.29 | +$0.56 (+11.9%) beat | $9.9B | +8.2% +8.6 vs SPY | +4.0% | +7.7% |
| Nov 4, 2025 AMC | 3Q2025 | $5.01 | $5.64 | +$0.63 (+12.5%) beat | $9.6B | +7.8% +7.5 vs SPY | +2.2% | +14.1% |
| Aug 5, 2025 AMC | $5.28 | $6.02 | +$0.74 (+14.0%) beat | — | -5.1% -5.9 vs SPY | -1.5% | -5.0% | |
| May 1, 2025 AMC | $4.26 | $4.90 | +$0.64 (+15.0%) beat | — | -0.9% -2.4 vs SPY | +2.7% | -4.1% | |
| Feb 4, 2025 AMC | $5.08 | $5.31 | +$0.23 (+4.5%) beat | — | +6.5% +6.1 vs SPY | +0.6% | +2.6% | |
| Oct 30, 2024 AMC | $5.11 | $5.58 | +$0.47 (+9.2%) beat | — | +1.5% +3.4 vs SPY | +0.7% | +2.0% | |
| Aug 6, 2024 AMC | $5.00 | $4.97 | −$0.03 (−0.6%) miss | — | -5.0% -4.3 vs SPY | -2.4% | -1.7% | |
| May 2, 2024 AMC | $3.89 | $3.96 | +$0.07 (+1.8%) beat | — | +11.8% +10.6 vs SPY | +12.6% | +12.4% | |
| Feb 6, 2024 AMC | $4.59 | $4.71 | +$0.12 (+2.6%) beat | — | -6.4% -7.2 vs SPY | -0.2% | -8.1% | |
| Oct 31, 2023 BMO | $4.68 | $4.96 | +$0.28 (+6.0%) beat | — | -2.9% -3.5 vs SPY | -2.8% | +3.7% | |
| Aug 3, 2023 AMC | $4.49 | $5.00 | +$0.51 (+11.4%) beat | — | +5.5% +5.9 vs SPY | +3.1% | +13.6% | |
| Apr 27, 2023 AMC | $3.85 | $3.98 | +$0.13 (+3.4%) beat | — | -0.2% -1.1 vs SPY | -1.5% | -3.5% | |
| Jan 31, 2023 AMC | $4.09 | $4.09 | $0.00 (0.0%) in line | — | -2.4% -3.4 vs SPY | -1.3% | -3.3% | |
| Nov 3, 2022 AMC | $4.45 | $4.70 | +$0.25 (+5.6%) beat | — | +1.2% -0.2 vs SPY | -1.5% | +9.4% | |
| Aug 4, 2022 AMC | $4.33 | $4.65 | +$0.32 (+7.4%) beat | — | -0.3% -0.1 vs SPY | -0.2% | +0.6% | |
| Apr 27, 2022 — | $4.12 | $4.25 | +$0.13 (+3.2%) beat | — | -4.3% -6.8 vs SPY | -5.2% | -5.1% | |
| Feb 7, 2022 AMC | $4.04 | $4.36 | +$0.32 (+7.9%) beat | — | +7.8% +7.0 vs SPY | +4.2% | +1.2% | |
| Nov 2, 2021 AMC | $4.22 | $4.67 | +$0.45 (+10.7%) beat | — | +1.8% +1.2 vs SPY | -1.6% | -1.2% | |
| Aug 3, 2021 AMC | $4.01 | $4.38 | +$0.37 (+9.2%) beat | — | — | — | — | |
| Apr 27, 2021 AMC | $4.04 | $3.70 | −$0.34 (−8.4%) miss | — | — | — | — | |
| Feb 2, 2021 AMC | $3.35 | $3.81 | +$0.46 (+13.7%) beat | — | — | — | — | |
| Oct 28, 2020 AMC | $3.75 | $4.37 | +$0.62 (+16.5%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $5.78 (27) | $5.48 – $6.16 | +2% | +0.4% | ▲13 ▼10 | $10.0B | +5% |
| Next quarter · Dec 31, 2026 | $5.80 (27) | $5.19 – $6.29 | +10% | -0.7% | ▲11 ▼12 | $10.3B | +4% |
| Current year · Dec 31, 2026 | $23.06 (33) | $22.47 – $23.90 | +6% | +3.0% | ▲31 ▼1 | $38.9B | +6% |
| Next year · Dec 31, 2027 | $24.45 (33) | $22.57 – $26.33 | +6% | +4.2% | ▲5 ▼2 | $40.3B | +4% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.